The Association for Professionals in Infection Control and Epidemiology (APIC), in partnership with the Accreditation Commission for Health Care (ACHC), has released new guidance to help healthcare facilities manage problematic Manufacturer Instructions for Use (MIFUs) for noncritical medical devices. This toolkit provides a standardized, evidence-informed framework for conducting risk assessments when manufacturer-specified cleaning or disinfection protocols are impractical, unavailable, or inconsistent with existing facility workflows.
Why Problematic MIFUs Create Operational Risks
Healthcare organizations often encounter situations where MIFUs for noncritical devices do not align with current operational realities. According to APIC, manufacturers may specify proprietary cleaning products that are no longer commercially available, or that conflict with established, hospital-wide purchasing agreements for equivalent chemical disinfectants. When facilities cannot adhere to these specific instructions, they face increased risks of staff confusion and inconsistent cleaning practices.
Historically, the lack of a universal process for addressing these discrepancies has led to inadequate risk assessments. This inconsistency can result in varying interpretations by regulatory surveyors. By failing to document safe, alternative approaches, facilities leave themselves vulnerable to compliance gaps.
The APIC toolkit specifically targets low-level disinfection for noncritical equipment. It does not advocate for bypassing manufacturer instructions for semi-critical or critical devices.
How the APIC-ACHC Toolkit Standardizes Risk Assessment
The new guidance introduces a structured, multidisciplinary template designed to formalize the evaluation of problematic MIFUs. Instead of relying on ad-hoc decisions, the framework encourages collaboration between infection preventionists, nursing leadership, quality teams, and facilities management. According to the ACHC, this collaborative approach is intended to ensure that any deviation from manufacturer instructions is backed by a rigorous, defensible, and evidence-informed assessment.
The toolkit provides evaluation algorithms that guide teams through the process of documenting why a specific MIFU is problematic and how a proposed alternative—such as a chemically equivalent disinfectant—maintains the same level of safety. This documentation serves as a critical record during regulatory inspections, demonstrating that the facility has proactively analyzed the risk and implemented a valid mitigation strategy.
Future Trends in Device Maintenance and Compliance
By standardizing the way facilities document and approve disinfection alternatives, organizations can reduce the burden on front-line staff while maintaining high standards of patient safety. The focus is shifting from "following instructions" to "managing risk" through evidence-based, collaborative decision-making.
When evaluating a problematic MIFU, involve your supply chain and procurement teams early. They can provide essential data on chemical equivalence and product availability that directly informs the risk assessment process.
Frequently Asked Questions
- Does the APIC toolkit allow hospitals to ignore manufacturer instructions?
No. The toolkit provides a framework for evaluating situations where instructions are impractical or impossible to follow, ensuring that any alternative approach is documented and evidence-based. - Which devices does this guidance cover?
The guidance is specifically focused on noncritical medical devices that require low-level disinfection. - Why is a multidisciplinary team necessary for these assessments?
According to APIC, including stakeholders from nursing, quality, and facilities management ensures that the assessment considers both clinical safety and real-world operational workflows.
Are you managing disinfection protocols at your facility? Share your experiences with MIFU challenges in the comments below or subscribe to our newsletter for more updates on infection prevention best practices.
